Metabolic Reprogramming of B Cells in Cancer: Effects of Altered Energetics

Area of Science:

• Immunology
• Cancer Biology
• Metabolic Research

Background:

• B cells are crucial for adaptive immunity and play a dual role in cancer, influencing both anti-tumor responses and tumor growth.
• Metabolic reprogramming within the tumor microenvironment (TME) significantly affects B cell behavior, differentiation, and function.
• Tumor-derived signals and nutrient availability in the TME reshape B cell energetics, impacting immune responses.

Purpose of the Study:

• To review the intricate relationship between B cell metabolism and cancer.
• To emphasize how altered cellular energetics in B cells affect their function and influence tumor progression.
• To highlight the potential of targeting B cell metabolic vulnerabilities for novel cancer therapies.

Main Methods:

• This review synthesizes existing research on B cell metabolism in the context of cancer.
• It analyzes the impact of the TME on B cell metabolic pathways, including glycolysis and oxidative phosphorylation (OXPHOS).
• The review discusses the implications of metabolic dysregulation on B cell phenotypes, such as regulatory B cells (Bregs).

Main Results:

• B cells in the TME preferentially utilize glycolysis, a metabolic shift that can be co-opted by tumors.
• Metabolic alterations lead to the development of immunosuppressive B cell subsets like Bregs, which hinder anti-tumor immunity.
• Nutrient deprivation and metabolic byproducts (e.g., lactate) in the TME further compromise effective B cell responses.

Conclusions:

• The metabolic plasticity of B cells is profoundly influenced by the tumor microenvironment, leading to complex outcomes in cancer.
• Dysfunctional B cell metabolism contributes to tumor progression and immune evasion, underscoring the need for targeted interventions.
• Identifying and exploiting the metabolic vulnerabilities of B cells within the tumor niche offers promising avenues for developing innovative cancer treatments.